GSK AGREES 3BN DRUG SETTLEMENT
November 4, 2011
GlaxoSmithKline has reached a record $3bn settlement in principle with the US government over aggressive sales and marketing practices of blockbuster medicines including its lung treatment Advair and the ...
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from Settlement News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
